POLB — Poolbeg Pharma Share News
0.000.00%
Last trade - 00:00- £28.59m
- £18.62m
RCS - Poolbeg Pharma PLC - POLB 001 to feature in CRS research programme
AnnouncementREG - Poolbeg Pharma PLC - POLB 001 European Patent granted
AnnouncementREG - Poolbeg Pharma PLC - Interim Results for the six months to 30 June 2025
AnnouncementREG - Poolbeg Pharma PLC - POLB 001 Phase 2a Trial Update
AnnouncementREG - Poolbeg Pharma PLC - Notification of Major Holdings
AnnouncementREG - Poolbeg Pharma PLC - Notification of Major Holdings
AnnouncementREG - AIM - AIM Notice - 25/06/2025
AnnouncementREG - Poolbeg Pharma PLC - Director/PDMR Shareholding
AnnouncementREG - Poolbeg Pharma PLC - Results of GM and AGM Meetings
AnnouncementREG - Poolbeg Pharma PLC - FDA Orphan Drug Designation granted for POLB 001
AnnouncementREG - Poolbeg Pharma PLC - Annual Report, AGM Notice & Circular
AnnouncementREG - Poolbeg Pharma PLC - Result of upsized oversubscribed BookBuild Offer
AnnouncementREG - Poolbeg Pharma PLC - Increase of BookBuild Offer
AnnouncementREG - Poolbeg Pharma PLC - Result of Placing and Notice of General Meeting
AnnouncementREG - Poolbeg Pharma PLC - Proposed Fundraising to raise approximately £4.1M
AnnouncementREG - Poolbeg Pharma PLC - Proposed Retail Offer to raise up to £100,000
AnnouncementREG - Poolbeg Pharma PLC - Results for the year ended 31 December 2024
AnnouncementRCS - Poolbeg Pharma PLC - Conference Participation in March & April 2025
AnnouncementRCS - Poolbeg Pharma PLC - POLB 001 Patent Granted in Korea
Announcement